Edwards Balance Sheet Analysis
EW Stock | USD 85.55 0.30 0.35% |
Edwards |
Most accounts from Edwards Lifesciences' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Edwards Lifesciences Corp current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Edwards Lifesciences Valuation and Edwards Lifesciences Correlation analysis. At this time, Edwards Lifesciences' Liabilities And Stockholders Equity is fairly stable compared to the past year. Inventory is likely to climb to about 1.2 B in 2024, whereas Good Will is likely to drop slightly above 688.6 M in 2024.
2021 | 2022 | 2023 | 2024 (projected) | Other Current Liabilities | 3.9M | 311M | 15.2M | 14.4M | Total Assets | 8.5B | 8.3B | 9.4B | 9.8B |
Edwards Lifesciences balance sheet Correlations
Click cells to compare fundamentals
Edwards Lifesciences Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Edwards Lifesciences balance sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 6.5B | 7.2B | 8.5B | 8.3B | 9.4B | 9.8B | |
Other Current Liab | 6.4M | 39.3M | 3.9M | 311M | 15.2M | 14.4M | |
Retained Earnings | 3.7B | 4.6B | 6.1B | 7.6B | 9.0B | 9.4B | |
Net Receivables | 599.1M | 602.8M | 664.9M | 699.1M | 836.9M | 878.7M | |
Good Will | 1.2B | 1.2B | 1.2B | 1.2B | 1.3B | 688.6M | |
Inventory | 640.9M | 802.3M | 726.7M | 875.5M | 1.2B | 1.2B | |
Other Current Assets | 168M | 208.2M | 237.1M | 195.9M | 239.3M | 251.3M | |
Total Liab | 2.3B | 2.7B | 2.7B | 2.5B | 2.6B | 1.4B | |
Total Current Assets | 3.0B | 3.1B | 3.2B | 3.1B | 4.0B | 4.2B | |
Other Liab | 784.1M | 1.1B | 969.6M | 797.6M | 917.2M | 963.1M | |
Net Debt | (500.3M) | (488.3M) | (172.5M) | (77.7M) | (449.1M) | (426.6M) | |
Accounts Payable | 180.4M | 196.5M | 204.5M | 201.9M | 201.4M | 139.5M | |
Cash | 1.2B | 1.2B | 862.8M | 769M | 1.1B | 1.2B | |
Other Assets | 274M | 1.2B | 357.5M | 783.1M | 900.6M | 945.6M | |
Long Term Debt | 594.4M | 595M | 595.7M | 596.3M | 597M | 425.6M | |
Short Term Debt | 598M | 0.0 | 25.5M | 27.2M | 24.9M | 23.7M | |
Intangible Assets | 336.5M | 331.4M | 323.6M | 285.2M | 428.4M | 449.8M | |
Common Stock | 218.1M | 636.4M | 642M | 646.3M | 650.5M | 683.0M | |
Treasury Stock | (1.0B) | (1.3B) | (1.9B) | (2.4B) | (2.2B) | (2.1B) | |
Net Tangible Assets | 2.9B | 3.4B | 4.3B | 4.4B | 5.0B | 5.3B | |
Capital Surpluse | 1.6B | 1.4B | 1.7B | 2.0B | 2.3B | 1.2B |
Pair Trading with Edwards Lifesciences
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Edwards Lifesciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Edwards Lifesciences will appreciate offsetting losses from the drop in the long position's value.Moving together with Edwards Stock
0.71 | DXCM | DexCom Inc | PairCorr |
Moving against Edwards Stock
0.65 | OM | Outset MedicalInc Trending | PairCorr |
The ability to find closely correlated positions to Edwards Lifesciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Edwards Lifesciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Edwards Lifesciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Edwards Lifesciences Corp to buy it.
The correlation of Edwards Lifesciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Edwards Lifesciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Edwards Lifesciences Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Edwards Lifesciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Edwards Lifesciences Valuation and Edwards Lifesciences Correlation analysis. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Complementary Tools for Edwards Stock analysis
When running Edwards Lifesciences' price analysis, check to measure Edwards Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Edwards Lifesciences is operating at the current time. Most of Edwards Lifesciences' value examination focuses on studying past and present price action to predict the probability of Edwards Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Edwards Lifesciences' price. Additionally, you may evaluate how the addition of Edwards Lifesciences to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Stocks Directory Find actively traded stocks across global markets |
Is Edwards Lifesciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Edwards Lifesciences. If investors know Edwards will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Edwards Lifesciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.036 | Earnings Share 2.32 | Revenue Per Share 10.151 | Quarterly Revenue Growth 0.095 | Return On Assets 0.1205 |
The market value of Edwards Lifesciences Corp is measured differently than its book value, which is the value of Edwards that is recorded on the company's balance sheet. Investors also form their own opinion of Edwards Lifesciences' value that differs from its market value or its book value, called intrinsic value, which is Edwards Lifesciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Edwards Lifesciences' market value can be influenced by many factors that don't directly affect Edwards Lifesciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Edwards Lifesciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Edwards Lifesciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Edwards Lifesciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.